ICU Medical, Inc. (NASDAQ:ICUI) headquartered in San Clemente, will host a conference call for the investment community to discuss the 3Q20 earnings result on 5th November 2020 at 4:30 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.icumed.com
Earnings Expectation
ICU Medical, Inc. is reporting third quarter financial results on Thursday 5th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, ICUI is expected to report 3Q20 income of $ 1.31 per share from revenue of $ 284.70 million.
For the full year, analysts anticipate top line of $ 1184.10 million, while looking forward to income of $ 6.40 per share bottom line.
The Company Outlook
Full Year 2020 bottomline are predicted in a range of $ 5.95 ~ $ 6.65 per share
Click Here For More Historical Outlooks Of ICU Medical, Inc.
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patients vein.
